Evidence map›Paper›PMID 33765944›Full record

ArticleBMC infectious diseases2021

Improved detection of microbiological pathogens: role of partner and non-governmental organizations.

Michael Owusu, Bernard Nkrumah, Godfred Acheampong, Ebenezer Kofi Mensah, Abass Abdul-Karim Komei, Festus Kofi Sroda, Sambian David, Shannon Emery, Lucy Maryogo Robinson, Kwame Asante and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Michael OwusuCentre for Health Systems Strengthening, Kumasi, Ghana. michaelowusu80@gmail.com.ORCID http://orcid.org/0000-0001-5066-150X
Bernard NkrumahAfrican Field Epidemiology Network, Accra, Ghana.
Godfred AcheampongCentre for Health Systems Strengthening, Kumasi, Ghana.
Ebenezer Kofi MensahSekondi Public Health Laboratory, Ghana Health Service, Sekondi, Ghana.
Abass Abdul-Karim KomeiTamale Public Health Laboratory, Ghana Health Service, Tamale, Ghana.
Festus Kofi SrodaKumasi Public Health Laboratory, Ghana Health Service, Kumasi, Ghana.
Sambian DavidCentre for Health Systems Strengthening, Kumasi, Ghana.
Shannon EmeryAssociation of Public Health Laboratories, Silver Springs, MD, USA.
Lucy Maryogo RobinsonAssociation of Public Health Laboratories, Silver Springs, MD, USA.
Kwame AsanteAssociation of Public Health Laboratories, Silver Springs, MD, USA.
David OpareNational Public Health and Reference Laboratory, Accra, Ghana.
Ghana Health Service · GHAssociation of Public Health Laboratories · USKumasi Centre for Collaborative Research in Tropical Medicine · GHKwame Nkrumah University of Science and Technology · GH

Funding

CDC HHS NA
6 · The paper itself

Abstract

backgroundProper detection of disease-causing organisms is very critical in controlling the course of outbreaks and avoiding large-scale epidemics. Nonetheless, availability of resources to address these gaps have been difficult due to limited funding. This report sought to highlight the importance of in-country partners and non-governmental organizations in improving detection of microbiological organisms in Ghanaian Public Health Laboratories (PHLs). METHODS/CONTEXT: This study was conducted between June, 2018 to August, 2019. U. S CDC engaged the Centre for Health Systems Strengthening (CfHSS) through the Association of Public Health Laboratories to design and implement strategies for strengthening three PHLs in Ghana. An assessment of the three PHLs was done using the WHO/CDS/CSR/ISR/2001.2 assessment tool. Based on findings from the assessments, partner organizations (CfHSS/APHL/CDC) serviced and procured microbiological equipment, laboratory reagents and logistics. CfHSS provided in-house mentoring and consultants to assist with capacity building in detection of epidemic-prone infectious pathogens by performing microbiological cultures and antimicrobial susceptibility tests.

resultsA total of 3902 samples were tested: blood (1107), urine (1742), stool (249) and cerebrospinal fluid (CSF) (804). All-inclusive, 593 pathogenic bacteria were isolated from blood cultures (70; 11.8%); urine cultures (356; 60%); stool cultures (19; 3.2%) and from CSF samples (148; 25%). The most predominant pathogens isolated from blood, urine and stool were Staphylococcus aureus (22/70; 31%), Escherichia coli (153/356; 43%) and Vibrio parahaemolyticus (5/19; 26.3%), respectively. In CSF samples, Streptococcus pneumoniae was the most frequent pathogen detected (80/148; 54.1%). New bacterial species such as Pastuerella pneumotropica, Klebsiella oxytoca, Vibrio parahaemolyticus, and Halfnia alvei were also identified with the aid of Analytical Profile Index (API) kits that were introduced as part of this implementation. Streptococcus pneumoniae and Neisseria meningitidis detections in CSF were highest during the hot dry season. Antimicrobial susceptibility test revealed high rate of S. aureus, K. pneumoniae and E. coli resistance to gentamicin (35-55%). In urine, E. coli was highly resistant to ciprofloxacin (39.2%) and ampicillin (34%).

conclusionDetection of epidemic-prone pathogens can be greatly improved if laboratory capacity is strengthened. In-country partner organizations are encouraged to support this move to ensure accurate diagnosis of diseases and correct antimicrobial testing.

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsBloodCerebrospinal FluidDrug Resistance, BacterialFecesGhanaHumansLaboratoriesMicrobial Sensitivity TestsOrganizationsRetrospective StudiesSeasonsUrineAnti-Bacterial AgentsDetectionNon-governmental organizationPathogensPublic health laboratories

Identifiers

PMID33765944
PMCPMC7993523
OpenAlexW3137026183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.